Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
ABSTRACT. We examined the susceptibility in vitro of 99 isolates of Mycoplasma (M. bovirhinis, M. bovis, M. alkalescens and M. bovoculi) and one of Acholeplasma laidlawii collected in 2008 and 2009 from Japanese homebred cattle and cows imported from Australia to 13 antimicrobial agents. Mycoplasma species isolated from homebred cattle were susceptible to spectinomycin and fluoroquinolones but resistant to macrolides, tetracyclines, thiamphenicol and flumequine. Kanamycin, lincomycin and chloramphenicol maintained intermediate effectiveness against these species. The isolates from the imported cows maintained sufficient susceptibility to all antimicrobials examined except for erythromycin and thiamphenicol. These results showed that four species of Mycoplasma isolated from Japanese homebred cattle had obviously higher drug resistance compared with previous reports, even within this decade.KEY WORDS: bovine respiratory diseases, drug resistance, Mycoplasma spp.J. Vet. Med. Sci. 72(12): 1661-1663, 2010 Bovine respiratory disease complex (BRDC) caused by several combinations of viral and bacterial infections together with stress is a significant problem that has considerable economic impact on the cattle industry [4,12]. Mycoplasma is a causative agent of BRDC [2,6,7,10,12]. Because vaccination of cattle to prevent Mycoplasma infection has not yet been approved in Japan, other approaches are needed, such as preventing bacterial invasion of farms through hygiene management, preventing respiratory symptoms through nutritional management and antibiotic treatment of cattle with abnormal respiratory manifestations. Although the antimicrobial susceptibility of Mycoplasma species has changed [6,7,10], there has been no report of examination of the susceptibility in Japan since isolates were collected from 1996-1997 [6]. Therefore, this study examined the antimicrobial susceptibility of Mycoplasma strains recently isolated from cattle in Japan.We analyzed 99 isolates of Mycoplasma (M. bovirhinis, M. bovis, M. alkalescens and M. bovoculi) and one of Acholeplasma laidlawii collected in 2008 and 2009 from Japanese homebred cattle that were 15 days to 11 months old at 33 farms in Kyusyu and healthy cows imported from Australia that were 14 to 15 months old. At the time of sampling, the Australian cattle were isolated from other cows because of quarantine restrictions at the destination farm.We examined the minimum inhibitory concentrations (MICs) of 13 antimicrobial agents (kanamycin, spectinomycin, erythromycin, tylosin, tilmicosin, lincomycin, oxytetracycline, chlortetracycline, chloramphenicol, thiamphenicol, flumequine, enrofloxacin and danofloxacin) required to completely suppress the growth of the four species of Mycoplasma and A. laidlawii. The MICs were determined using agar dilution according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [3] and a previous report [5]. Mycoplasma species and A. laidlawii were grown and diluted 1:100 in M broth [9]. Bacterial suspensions (about 10 6 colony formi...
ABSTRACT. We examined the susceptibility in vitro of 99 isolates of Mycoplasma (M. bovirhinis, M. bovis, M. alkalescens and M. bovoculi) and one of Acholeplasma laidlawii collected in 2008 and 2009 from Japanese homebred cattle and cows imported from Australia to 13 antimicrobial agents. Mycoplasma species isolated from homebred cattle were susceptible to spectinomycin and fluoroquinolones but resistant to macrolides, tetracyclines, thiamphenicol and flumequine. Kanamycin, lincomycin and chloramphenicol maintained intermediate effectiveness against these species. The isolates from the imported cows maintained sufficient susceptibility to all antimicrobials examined except for erythromycin and thiamphenicol. These results showed that four species of Mycoplasma isolated from Japanese homebred cattle had obviously higher drug resistance compared with previous reports, even within this decade.KEY WORDS: bovine respiratory diseases, drug resistance, Mycoplasma spp.J. Vet. Med. Sci. 72(12): 1661-1663, 2010 Bovine respiratory disease complex (BRDC) caused by several combinations of viral and bacterial infections together with stress is a significant problem that has considerable economic impact on the cattle industry [4,12]. Mycoplasma is a causative agent of BRDC [2,6,7,10,12]. Because vaccination of cattle to prevent Mycoplasma infection has not yet been approved in Japan, other approaches are needed, such as preventing bacterial invasion of farms through hygiene management, preventing respiratory symptoms through nutritional management and antibiotic treatment of cattle with abnormal respiratory manifestations. Although the antimicrobial susceptibility of Mycoplasma species has changed [6,7,10], there has been no report of examination of the susceptibility in Japan since isolates were collected from 1996-1997 [6]. Therefore, this study examined the antimicrobial susceptibility of Mycoplasma strains recently isolated from cattle in Japan.We analyzed 99 isolates of Mycoplasma (M. bovirhinis, M. bovis, M. alkalescens and M. bovoculi) and one of Acholeplasma laidlawii collected in 2008 and 2009 from Japanese homebred cattle that were 15 days to 11 months old at 33 farms in Kyusyu and healthy cows imported from Australia that were 14 to 15 months old. At the time of sampling, the Australian cattle were isolated from other cows because of quarantine restrictions at the destination farm.We examined the minimum inhibitory concentrations (MICs) of 13 antimicrobial agents (kanamycin, spectinomycin, erythromycin, tylosin, tilmicosin, lincomycin, oxytetracycline, chlortetracycline, chloramphenicol, thiamphenicol, flumequine, enrofloxacin and danofloxacin) required to completely suppress the growth of the four species of Mycoplasma and A. laidlawii. The MICs were determined using agar dilution according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [3] and a previous report [5]. Mycoplasma species and A. laidlawii were grown and diluted 1:100 in M broth [9]. Bacterial suspensions (about 10 6 colony formi...
Mycoplasma bovis is an important and emerging cause of respiratory disease and arthritis in feedlot cattle and young dairy and veal calves, and has a variety of other disease manifestations in cattle. M. bovis is certainly capable of causing acute respiratory disease in cattle, yet the attributable fraction has been difficult to estimate. In contrast, M. bovis is more accepted as a cause of chronic bronchopneumonia with caseous and perhaps coagulative necrosis, characterized by persistent infection that seems poorly responsive to many antibiotics. An understanding of the disease has been recently advanced by comparisons of natural and experimentally induced disease, development of molecular diagnostic tools, and understanding some aspects of virulence, yet uncertainties regarding protective immunity, the importance of genotypic diversity, mechanisms of virulence, and the role of co-pathogens have restricted our understanding of pathogenesis and our ability to effectively control the disease. This review critically considers the relationship between M. bovis infection and the various manifestations of the bovine respiratory disease complex, and addresses the pathogenesis, clinical and pathologic sequelae, laboratory diagnosis and control of disease resulting from M. bovis infection in the bovine respiratory tract.
Nasal swabs of 293 calves were examined for Mycoplasma. The samples were collected from calves affected with respiratory diseases on 71 farms in various parts of Japan between 1996 and 1997. Mycoplasma bovirhinis was isolated from 47 of 293 calves (16.0%). Mycoplasma alkalescens, M. bovis, M. arginini, M. bovigenitalium and Acholeplasma spp. were isolated from 19 (6.5%), seven (2.4%), four (1.4%), four (1.4%) and 18 (6.1%) calves, respectively. Pasteurella multocida and P. haemolytica were isolated from 60% of Mycoplasma-positive calves. However, other bacteria were not isolated from calves. To evaluate the antimicrobial susceptibility of their isolates, 68 M. bovirhinis, 21 M. alkalescens and 10 M. bovis strains were examined for 12 antimicrobial agents. All isolates showed higher susceptibility to tiamulin than to the other drugs used in the study. However, erythromycin had no effect on any of the Mycoplasma strains studied. The field isolates were less susceptible than the type strains to some drugs, such as spiramycin, oxytetracycline and tylosin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.